MO899PRURITUS IN CHRONIC HEMODIALYSIS PATIENTS ANDS ITS IMPACT ON QUALITY OF LIFE

Autor: Khawla Kammoun, Salma Toumi, Ikram Agerbi, Soumaya Yaich, Asma Amouri, Faten Ghabi, Mohamed Benhmida, Hanen Chaker, Najla Dammak, Abdelrahmen Masmoudi
Rok vydání: 2021
Předmět:
Zdroj: Nephrology Dialysis Transplantation. 36
ISSN: 1460-2385
0931-0509
Popis: Background and Aims Pruritus is a common symptom in chronic hemodialysis patients, its intensity varies from patient to patient and which plays a major role in impairing their quality of life. Its pathophysiology is poorly understood and its management remains a challenge. The main objective of our study is to estimate the frequency of pruritus in our population and its impact on their quality of life. Material and methods This is a cross-sectional study involving 53 patients carried out in the dialysis unit of the CHU Hédi chaker in sfax. The DLQI (Dermatology Life Quality Index), the Pittsburgh Sleep Quality Index (PSQI) and the verbal analogue scale to specify the intensity of pruritus were used to assess the impact of pruritus on quality of life. Results The mean age of our patients was 48 ± 28 years with a predominance of men (60%). The mean duration on hemodialysis was 5.4 years. The prevalence of pruritus was 28% of cases. Pruritus affects 75% of the body surface in 90% of patients, an intensity greater than or equal to 5 in 93.33% of cases on an intensity scale of 0 to 10, the impact was moderate on the quality of life according to the DLQI in 66.66% of the cases, 86.66% of the patients presented a nocturnal recrudescence of the pruritus, and an alteration of the quality of sleep was present in 73.33% of the cases according to the PSQI. The Comparison of the groups with (G1) or without pruritus (G2) showed the predominance of hyperposphoraemia in the first group with averages of 1.92mmol / l and 1.4mmol / l respectively in G1 and G2 Conclusion Pruritus remains the most frequent complaint for hemodialysis patients, which in our patients was linked mainly to hyperposphoraemia requiring optimization of phosphorus chelators and hemodialysis measures.
Databáze: OpenAIRE
Externí odkaz: